Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

IMPORTANCE: Patient-reported outcomes (PROs), such as quality of life (QOL) and symptoms, are often associated with clinical outcomes in patients with cancer. In practice, oncologists use serum tumor markers (TMs) (ie, carcinoembryonic antigen [CEA] and carbohydrate antigen 19-9 [CA 19-9]) and imagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarnagin, Joy X., Saraf, Anurag, Baiev, Islam, Chi, Gary, van Seventer, Emily E., Mojtahed, Amirkasra, Allen, Jill N., Clark, Jeffrey W., Blaszkowsky, Lawrence, Giantonio, Bruce J., Weekes, Colin D., Klempner, Samuel J., Franses, Joseph W., Roeland, Eric J., Goyal, Lipika, Siravegna, Giulia, Horick, Nora, Corcoran, Ryan B., Nipp, Ryan D., Parikh, Aparna R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656643/
https://www.ncbi.nlm.nih.gov/pubmed/37976066
http://dx.doi.org/10.1001/jamanetworkopen.2023.43512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656643/
https://www.ncbi.nlm.nih.gov/pubmed/37976066
http://dx.doi.org/10.1001/jamanetworkopen.2023.43512

Ejemplares similares